Marston NA, Bohula EA, Bhatia AK, De Ferrari GM, et al. Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes: Results From the VESALIUS-CV Trial. JAMA 2026 Mar 28:e263277. doi: 10.1001/jama.2026.3277.
PMID: 41903215